Kyverna Therapeutics, Inc.'s total assets for Q4 2023 were $75.19M, a decrease of -18.70% from the previous quarter. KYTX total liabilities were $26.02M for the fiscal quarter, a 9.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.